Glucose-Induced Activation of mTORC1 is Associated with Hexokinase2 Binding to Sestrins in HEK293T Cells.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
04 2023
Historique:
received: 29 07 2022
revised: 25 10 2022
accepted: 23 11 2022
pmc-release: 22 12 2023
medline: 18 4 2023
entrez: 15 4 2023
pubmed: 16 4 2023
Statut: ppublish

Résumé

Sestrins (SESN1-3) act as proximal sensors in leucine-induced activation of the protein kinase mechanistic target of rapamycin (mTOR) in complex 1 (mTORC1), a key regulator of cell growth and metabolism. In the present study, the hypothesis that SESNs also mediate glucose-induced activation of mTORC1 was tested. Rats underwent overnight fasting, and in the morning, either saline or a glucose solution (4 g⋅kg Glucose administration to fasted rats promoted mTORC1 activation. Similarly, glucose readdition (GluAB) to the medium of glucose-deprived WT cells also promoted mTORC1 activation. By contrast, SESNTKO cells demonstrated attenuated mTORC1 activation following GluAB compared with WT cells. Interestingly, HK2 associated with all 3 SESNs in a glucose-dependent manner, i.e., HK2 abundance in SESN immunoprecipitates was high in cells deprived of glucose and decreased in response to GluAB. Moreover, similar to SESNTKO cells, the sensitivity of mTORC1 to GluAB was attenuated in HK2KO cells compared with WT cells. The results of this study demonstrate that the SESNs and HK2 play important roles in glucose-induced mTORC1 activation in HEK293T cells. However, unlike leucine-induced mTORC1 activation, the effect was independent of the changes in SESN-GATOR2 interaction, and instead, it was associated with alterations in the association of SESNs with HK2.

Sections du résumé

BACKGROUND
Sestrins (SESN1-3) act as proximal sensors in leucine-induced activation of the protein kinase mechanistic target of rapamycin (mTOR) in complex 1 (mTORC1), a key regulator of cell growth and metabolism.
OBJECTIVE
In the present study, the hypothesis that SESNs also mediate glucose-induced activation of mTORC1 was tested.
METHODS
Rats underwent overnight fasting, and in the morning, either saline or a glucose solution (4 g⋅kg
RESULTS
Glucose administration to fasted rats promoted mTORC1 activation. Similarly, glucose readdition (GluAB) to the medium of glucose-deprived WT cells also promoted mTORC1 activation. By contrast, SESNTKO cells demonstrated attenuated mTORC1 activation following GluAB compared with WT cells. Interestingly, HK2 associated with all 3 SESNs in a glucose-dependent manner, i.e., HK2 abundance in SESN immunoprecipitates was high in cells deprived of glucose and decreased in response to GluAB. Moreover, similar to SESNTKO cells, the sensitivity of mTORC1 to GluAB was attenuated in HK2KO cells compared with WT cells.
CONCLUSIONS
The results of this study demonstrate that the SESNs and HK2 play important roles in glucose-induced mTORC1 activation in HEK293T cells. However, unlike leucine-induced mTORC1 activation, the effect was independent of the changes in SESN-GATOR2 interaction, and instead, it was associated with alterations in the association of SESNs with HK2.

Identifiants

pubmed: 37061344
pii: S0022-3166(22)13243-8
doi: 10.1016/j.tjnut.2022.11.021
pmc: PMC10273196
pii:
doi:

Substances chimiques

Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
Leucine GMW67QNF9C
Sestrins 0
Hexokinase EC 2.7.1.1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

988-998

Subventions

Organisme : NIDDK NIH HHS
ID : F32 DK126312
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK015658
Pays : United States
Organisme : NIAAA NIH HHS
ID : R37 AA011290
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.

Références

Nat Commun. 2018 Jul 26;9(1):2935
pubmed: 30050148
Antioxid Redox Signal. 2011 Sep 15;15(6):1679-90
pubmed: 20712410
Diabetes. 2015 Apr;64(4):1211-23
pubmed: 25377878
Cell Signal. 2016 Aug;28(8):896-906
pubmed: 27010498
Dev Cell. 2022 Mar 28;57(6):691-706
pubmed: 35316619
Nat Metab. 2020 Sep;2(9):893-901
pubmed: 32719541
Cell Rep. 2014 Oct 9;9(1):1-8
pubmed: 25263562
Blood. 2005 Dec 15;106(13):4034-42
pubmed: 16051738
Nutrients. 2017 Sep 04;9(9):
pubmed: 28869573
Cell Metab. 2013 Dec 3;18(6):792-801
pubmed: 24055102
Front Nutr. 2021 Jan 14;7:628405
pubmed: 33521042
Nat Metab. 2020 Sep;2(9):817-828
pubmed: 32747792
Sci Rep. 2015 Mar 30;5:9502
pubmed: 25819761
J Nutr. 2000 Oct;130(10):2413-9
pubmed: 11015466
Nature. 2013 Jan 31;493(7434):679-83
pubmed: 23263183
Cell Metab. 2012 Sep 5;16(3):311-21
pubmed: 22958918
Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E241-8
pubmed: 20484009
Cell Rep. 2014 Nov 20;9(4):1281-91
pubmed: 25457612
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E817-E828
pubmed: 30835510
Cell. 2008 Aug 8;134(3):451-60
pubmed: 18692468
Cell Metab. 2010 May 5;11(5):390-401
pubmed: 20444419
Trends Neurosci. 2013 Oct;36(10):587-97
pubmed: 23968694
Am J Physiol Renal Physiol. 2011 Sep;301(3):F588-96
pubmed: 21613414
Am J Physiol Endocrinol Metab. 2013 Dec 1;305(11):E1408-14
pubmed: 24129397
Endocrinology. 1991 Feb;128(2):645-53
pubmed: 1989854
J Cell Sci. 2019 Nov 13;132(21):
pubmed: 31722960
Mol Cell. 2014 Feb 20;53(4):521-33
pubmed: 24462113
J Appl Physiol (1985). 2019 Oct 1;127(4):895-904
pubmed: 31369326
Science. 2016 Jan 1;351(6268):43-8
pubmed: 26449471
Cell Death Differ. 2015 Feb;22(2):248-57
pubmed: 25323588
Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3368-3377
pubmed: 30048751

Auteurs

Paul A Roberson (PA)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Gregory N Kincheloe (GN)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Jaclyn E Welles (JE)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Dandan Xu (D)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Mahalia Sam-Clarke (M)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Paul S MacLean (PS)

Divisions of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Charles H Lang (CH)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Leonard S Jefferson (LS)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA.

Scot R Kimball (SR)

Penn State College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA. Electronic address: skimball@psu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH